Drug Trial Radar · NCT07743450
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Last checked: Nov 19, 2026Latest source record: Sep 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,560
Planned (sponsor's estimate)
Start
Aug 28, 2026
Primary completion
Jul 2028
Study completion Jul 2028
Sponsor
- Lead sponsor
- Ascletis Pharma (China) Co., LimitedIndustry
- Sponsor type
- Industry
- First posted
- Aug 3, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study ASC30-302 (AURORA-2) is a Phase III, global, multicenter, randomized, double-blind, placebo-controlled study to investigate the long-term efficacy, safety, and tolerability of three maintenance doses of once-daily oral ASC30 compared with placebo in participants with obesity or overweight and T2DM.
Conditions
- Obesity
- Overweight
- Chronic Weight Management
- Type 2 Diabetes Mellitus
Interventions
ASC30 tablets A1Drug
ASC30 tablets A1 administered orally once daily.
PlaceboDrug
Matching placebo tablets administered orally once daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent change from baseline in body weightTime frame: Baseline to Week 72
Locations
135 sites in 6 countries. Site status is shown where the registry gives one.
AURORA-2 Clinical Site
Birmingham, Alabama · Not yet recruiting
AURORA-2 Clinical Site
Huntsville, Alabama · Not yet recruiting
AURORA-2 Clinical Site
Peoria, Arizona · Not yet recruiting
AURORA-2 Clinical Site
Phoenix, Arizona · Recruiting
AURORA-2 Clinical Site
Tucson, Arizona · Not yet recruiting
AURORA-2 Clinical Site
Little Rock, Arkansas · Not yet recruiting
AURORA-2 Clinical Site
Banning, California · Not yet recruiting
AURORA-2 Clinical Site
Chula Vista, California · Not yet recruiting
AURORA-2 Clinical Site
Covina, California · Not yet recruiting
AURORA-2 Clinical Site
Gardena, California · Not yet recruiting
AURORA-2 Clinical Site
La Mesa, California · Not yet recruiting
AURORA-2 Clinical Site
Los Angeles, California · Not yet recruiting
AURORA-2 Clinical Site
Sacramento, California · Not yet recruiting
AURORA-2 Clinical Site
Tarzana, California · Not yet recruiting
AURORA-2 Clinical Site
Tustin, California · Not yet recruiting
AURORA-2 Clinical Site
Washington D.C., District of Columbia · Not yet recruiting
AURORA-2 Clinical Site
Boca Raton, Florida · Not yet recruiting
AURORA-2 Clinical Site
Daytona Beach, Florida · Not yet recruiting
AURORA-2 Clinical Site
Jacksonville, Florida · Not yet recruiting
AURORA-2 Clinical Site
Leesburg, Florida · Not yet recruiting
AURORA-2 Clinical Site
Melbourne, Florida · Recruiting
AURORA-2 Clinical Site
South Miami, Florida · Not yet recruiting
AURORA-2 Clinical Site
Tampa, Florida · Not yet recruiting
AURORA-2 Clinical Site
The Villages, Florida · Recruiting
AURORA-2 Clinical Site
Winter Park, Florida · Not yet recruiting
AURORA-2 Clinical Site
Canton, Georgia · Not yet recruiting
AURORA-2 Clinical Site
Decatur, Georgia · Not yet recruiting
AURORA-2 Clinical Site
Union City, Georgia · Not yet recruiting
AURORA-2 Clinical Site
Boise, Idaho · Not yet recruiting
AURORA-2 Clinical Site
Schaumburg, Illinois · Not yet recruiting
AURORA-2 Clinical Site
Evansville, Indiana · Recruiting
AURORA-2 Clinical Site
Indianapolis, Indiana · Not yet recruiting
AURORA-2 Clinical Site
Valparaiso, Indiana · Not yet recruiting
AURORA-2 Clinical Site
Kansas City, Kansas · Not yet recruiting
AURORA-2 Clinical Site
Baton Rouge, Louisiana · Not yet recruiting
AURORA-2 Clinical Site
Metairie, Louisiana · Not yet recruiting
AURORA-2 Clinical Site
Bowie, Maryland · Not yet recruiting
AURORA-2 Clinical Site
Rockville, Maryland · Not yet recruiting
AURORA-2 Clinical Site
Southfield, Michigan · Not yet recruiting
AURORA-2 Clinical Site
Mankato, Minnesota · Not yet recruiting
Showing 40 of 135 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.